U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H15NOS2
Molecular Weight 337.459
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of IMB-10

SMILES

CC1=CC=CC=C1N2C(=S)S\C(=C/C=C/C3=CC=CC=C3)C2=O

InChI

InChIKey=UYZLENPCNZVWQZ-DNZSEPECSA-N
InChI=1S/C19H15NOS2/c1-14-8-5-6-12-16(14)20-18(21)17(23-19(20)22)13-7-11-15-9-3-2-4-10-15/h2-13H,1H3/b11-7+,17-13-

HIDE SMILES / InChI
IMB-10 stabilizes binding of alpha(M)beta(2) to its endogenous ligands proMMP-9 and fibrinogen. It inhibited alpha(M)beta(2)-dependent migration in vitro and inflammation-induced neutrophil emigration in vivo. IMB-10 therapy inhibited the growth of both leukemia and lymphoma xenografts and significantly prolonged the survival of the mice with lymphoma. IMB-10 has potential as a therapy for leukocytic malignancies, particularly for lymphomas.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.4 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators.
2017-07-05
Small molecule agonist of very late antigen-4 (VLA-4) integrin induces progenitor cell adhesion.
2013-07-05
Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease.
2011-09-06
Identification of novel agonists of the integrin CD11b/CD18.
2009-12-15
AlphaMbeta2 integrin modulator exerts antitumor activity in vivo.
2008-01-30
A simple, no-wash cell adhesion-based high-throughput assay for the discovery of small-molecule regulators of the integrin CD11b/CD18.
2007-04
Stabilization of the activated alphaMbeta2 integrin by a small molecule inhibits leukocyte migration and recruitment.
2006-03-07
Patents

Patents

Sample Use Guides

Mice: 4 ug
Route of Administration: Intravenous
On a fibrinogen matrix, IMB-10 completely inhibited migration of THP-1 and OCI-AML-3 cells at a 25 µM concentration.
Name Type Language
IMB-10
Common Name English
4-THIAZOLIDINONE, 3-(2-METHYLPHENYL)-5-(3-PHENYL-2-PROPEN-1-YLIDENE)-2-THIOXO-
Preferred Name English
4-THIAZOLIDINONE, 3-(2-METHYLPHENYL)-5-(3-PHENYL-2-PROPENYLIDENE)-2-THIOXO-
Systematic Name English
Code System Code Type Description
CAS
307525-40-2
Created by admin on Mon Mar 31 22:07:33 GMT 2025 , Edited by admin on Mon Mar 31 22:07:33 GMT 2025
PRIMARY
EPA CompTox
DTXSID40184777
Created by admin on Mon Mar 31 22:07:33 GMT 2025 , Edited by admin on Mon Mar 31 22:07:33 GMT 2025
PRIMARY
PUBCHEM
1555648
Created by admin on Mon Mar 31 22:07:33 GMT 2025 , Edited by admin on Mon Mar 31 22:07:33 GMT 2025
PRIMARY
FDA UNII
9DDO6X234Z
Created by admin on Mon Mar 31 22:07:33 GMT 2025 , Edited by admin on Mon Mar 31 22:07:33 GMT 2025
PRIMARY